Epitope Lability of Phosphorylated Biomarkers of the DNA Damage Response Pathway Results in Increased Vulnerability to Effects of Delayed or Incomplete Formalin Fixation. (May 2023)
- Record Type:
- Journal Article
- Title:
- Epitope Lability of Phosphorylated Biomarkers of the DNA Damage Response Pathway Results in Increased Vulnerability to Effects of Delayed or Incomplete Formalin Fixation. (May 2023)
- Main Title:
- Epitope Lability of Phosphorylated Biomarkers of the DNA Damage Response Pathway Results in Increased Vulnerability to Effects of Delayed or Incomplete Formalin Fixation
- Authors:
- Wiseman, Elizabeth J.
Moss, Jennifer I.
Atkinson, James
Baakza, Hana
Hayes, Emily
Willis, Sophie E.
Waring, Paul M.
Rodriguez Canales, Jaime
Jones, Gemma N. - Abstract:
- Phosphorylated biomarkers are crucial for our understanding of drug mechanism of action and dose selection during clinical trials, particularly for drugs that target protein kinases, such as DNA-damage-response (DDR) inhibitors. However, tissue fixation conditions needed to preserve DDR-specific phospho-biomarkers have not been previously investigated. Using xenograft tissues and tightly controlled formalin fixation conditions, we assessed how preanalytical factors affect phosphorylated DDR biomarkers pRAD50(Ser635), ɣH2AX(Ser139), pKAP1(Ser824), and non-phosphorylated biomarkers cMYC and ATM. Cold ischemia times ranged from 15 min to 6 hr, and the fixation duration ranged from 24 hr to 4 weeks. Epitopes pRAD50 and pKAP1 appeared the most labile assessed with staining loss after just 15 min of cold ischemia time, while ATM was more robust showing consistent expression up to 1 hr of cold ischemia. Notably, ɣH2AX expression was lost with formalin fixation over 48 hr. The use of core needle biopsies where possible and novel fixation methods such as the 2-step temperature-controlled formalin approach may improve phosphorylated biomarker preservation; however, practical challenges may affect wider clinical application. The most essential tissue-processing step when downstream analysis includes DDR phosphorylated biomarkers is immediate tissue submersion in formalin, without delay, upon excision from the patient, followed by room temperature fixation for 24 hr.
- Is Part Of:
- Journal of histochemistry and cytochemistry. Volume 71:Number 5(2023)
- Journal:
- Journal of histochemistry and cytochemistry
- Issue:
- Volume 71:Number 5(2023)
- Issue Display:
- Volume 71, Issue 5 (2023)
- Year:
- 2023
- Volume:
- 71
- Issue:
- 5
- Issue Sort Value:
- 2023-0071-0005-0000
- Page Start:
- 237
- Page End:
- 257
- Publication Date:
- 2023-05
- Subjects:
- ɣH2AX -- ATM -- c-MYC -- cold ischemia -- IHC -- pKAP1 -- pRAD50 -- tissue artifacts
Histochemistry -- Periodicals
Cytochemistry -- Periodicals
Histocytochemistry -- methods
Histological Techniques
572.05 - Journal URLs:
- http://www.jhc.org/ ↗
http://journals.sagepub.com/home/jhc ↗
http://www.sagepublications.com/ ↗ - DOI:
- 10.1369/00221554231174069 ↗
- Languages:
- English
- ISSNs:
- 0022-1554
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 26735.xml